Literature DB >> 11943707

Diverse tumorigenic pathways in ovarian serous carcinoma.

Gad Singer1, Robert J Kurman, Hsueh-Wei Chang, Sarah K R Cho, Ie-Ming Shih.   

Abstract

This study was undertaken to analyze genetic alterations in 108 sporadic serous ovarian neoplasms to elucidate ovarian serous carcinogenesis. Our results demonstrate that K-ras mutations occur in approximately 50% of serous borderline tumors (SBTs), non-invasive micropapillary serous carcinomas (MPSCs), and invasive micropapillary serous carcinomas, which represent a morphological continuum of tumor progression. Moreover, progressive increase in the degree of allelic imbalance of chromosomes 1p, 5q, 8p, 18q, 22q, and Xp was observed comparing serous borderline tumors to noninvasive and invasive micropapillary serous carcinomas. In contrast, high-grade (conventional serous carcinoma) tumors contained wild-type K-ras in all 23 cases studied and a high frequency of allelic imbalance even in small (early) primary tumors similar to that found in advanced stage tumors. Based on these findings, we propose a dualistic model for ovarian serous carcinogenesis. One pathway involves a stepwise progression from SBT to noninvasive and then invasive MPSC. The other pathway is characterized by rapid progression from the ovarian surface epithelium or inclusion cysts to a conventional (high-grade) serous carcinoma.

Entities:  

Mesh:

Year:  2002        PMID: 11943707      PMCID: PMC1867233          DOI: 10.1016/s0002-9440(10)62549-7

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  18 in total

1.  Molecular genetic analysis of appendiceal mucinous adenomas in identical twins, including one with pseudomyxoma peritonei.

Authors:  I M Shih; H Yan; D Speyrer; B M Shmookler; P H Sugarbaker; B M Ronnett
Journal:  Am J Surg Pathol       Date:  2001-08       Impact factor: 6.394

2.  Loss of heterozygosity in tumor cells requires re-evaluation: the data are biased by the size-dependent differential sensitivity of allele detection.

Authors:  J Liu; V I Zabarovska; E Braga; A Alimov; G Klein; E R Zabarovsky
Journal:  FEBS Lett       Date:  1999-11-26       Impact factor: 4.124

3.  Somatic genetic alterations (LOH) in benign, borderline and invasive ovarian tumours: intratumoral molecular heterogeneity.

Authors:  I Zborovskaya; A Gasparian; A Karseladze; I Elcheva; E Trofimova; K Driouch; M Trassard; A Tatosyan; R Lidereau
Journal:  Int J Cancer       Date:  1999-09-09       Impact factor: 7.396

4.  Top-down morphogenesis of colorectal tumors.

Authors:  I M Shih; T L Wang; G Traverso; K Romans; S R Hamilton; S Ben-Sasson; K W Kinzler; B Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-20       Impact factor: 11.205

5.  Evidence that genetic instability occurs at an early stage of colorectal tumorigenesis.

Authors:  I M Shih; W Zhou; S N Goodman; C Lengauer; K W Kinzler; B Vogelstein
Journal:  Cancer Res       Date:  2001-02-01       Impact factor: 12.701

6.  Human epithelial ovarian cancer allelotype.

Authors:  W Cliby; S Ritland; L Hartmann; M Dodson; K C Halling; G Keeney; K C Podratz; R B Jenkins
Journal:  Cancer Res       Date:  1993-05-15       Impact factor: 12.701

7.  Comparison of loss of heterozygosity patterns in invasive low-grade and high-grade epithelial ovarian carcinomas.

Authors:  M K Dodson; L C Hartmann; W A Cliby; K A DeLacey; G L Keeney; S R Ritland; J Q Su; K C Podratz; R B Jenkins
Journal:  Cancer Res       Date:  1993-10-01       Impact factor: 12.701

8.  Ki67 antigen immunostaining (MIB 1 monoclonal antibody) in serous ovarian tumors: index of proliferative activity with prognostic significance.

Authors:  G G Garzetti; A Ciavattini; G Goteri; M De Nictolis; D Stramazzotti; G Lucarini; G Biagini
Journal:  Gynecol Oncol       Date:  1995-02       Impact factor: 5.482

9.  Mutation of K-ras protooncogene in human ovarian epithelial tumors of borderline malignancy.

Authors:  S C Mok; D A Bell; R C Knapp; P M Fishbaugh; W R Welch; M G Muto; R S Berkowitz; S W Tsao
Journal:  Cancer Res       Date:  1993-04-01       Impact factor: 12.701

10.  Early de novo ovarian carcinoma. A study of fourteen cases.

Authors:  D A Bell; R E Scully
Journal:  Cancer       Date:  1994-04-01       Impact factor: 6.860

View more
  90 in total

Review 1.  Role of p53 and Rb in ovarian cancer.

Authors:  David C Corney; Andrea Flesken-Nikitin; Jinhyang Choi; Alexander Yu Nikitin
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

2.  Fallopian tube as main source for ovarian and pelvic (non-endometrial) serous carcinomas.

Authors:  Wenxin Zheng; Oluwole Fadare
Journal:  Int J Clin Exp Pathol       Date:  2012-03-25

Review 3.  Ovarian low-grade and high-grade serous carcinoma: pathogenesis, clinicopathologic and molecular biologic features, and diagnostic problems.

Authors:  Russell Vang; Ie-Ming Shih; Robert J Kurman
Journal:  Adv Anat Pathol       Date:  2009-09       Impact factor: 3.875

Review 4.  Tubal origin of ovarian endometriosis and clear cell and endometrioid carcinoma.

Authors:  Yiying Wang; Maggie Mang; Yue Wang; Lijie Wang; Robert Klein; Beihua Kong; Wenxin Zheng
Journal:  Am J Cancer Res       Date:  2015-02-15       Impact factor: 6.166

Review 5.  Origin of ovarian cancer: molecular profiling.

Authors:  Dilip Kumar Dutta; Indranil Dutta
Journal:  J Obstet Gynaecol India       Date:  2013-06-21

6.  The role of p53 as a surrogate marker for chemotherapeutical responsiveness in ovarian cancer.

Authors:  Dirk O Bauerschlag; Christian Schem; Marion T Weigel; Constantin Von Kaisenberg; Alexander Strauss; Thomas Bauknecht; Nicolai Maass; Ivo Meinhold-Heerlein
Journal:  J Cancer Res Clin Oncol       Date:  2010-01       Impact factor: 4.553

7.  Ovarian cancer pathogenesis: a model in evolution.

Authors:  Alison M Karst; Ronny Drapkin
Journal:  J Oncol       Date:  2009-09-06       Impact factor: 4.375

8.  Expression profiling identifies genes involved in neoplastic transformation of serous ovarian cancer.

Authors:  Melissa A Merritt; Peter G Parsons; Tanya R Newton; Adam C Martyn; Penelope M Webb; Adèle C Green; David J Papadimos; Glen M Boyle
Journal:  BMC Cancer       Date:  2009-10-23       Impact factor: 4.430

9.  Molecular abnormalities in ovarian cancer subtypes other than high-grade serous carcinoma.

Authors:  C Blake Gilks
Journal:  J Oncol       Date:  2009-12-30       Impact factor: 4.375

10.  Mutational analysis of KRAS, BRAF, and TP53 genes of ovarian serous carcinomas in Korean women.

Authors:  Yun-Hyun Cho; Dae-Yeon Kim; Jong-Hyeok Kim; Yong-Man Kim; Kyu-Rae Kim; Joo-Hyun Nam; Young-Tak Kim
Journal:  Yonsei Med J       Date:  2009-04-30       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.